1. 522PPrognostic value of neutrophil-lymphocite ratio in resected high risk colorectal cancer: An analysis of adjuvant TOSCA trial. (23rd October 2018) Authors: Petrelli, F; Rosati, G; Banzi, M; Zampino, M G; Pella, N; Di Bartolomeo, M; Maiello, E; Bidoli, P; Ferrari, D; Rimassa, L; Labianca, R; Scartozzi, M; Lonardi, S; de Placido, S; Zaniboni, A; Sobrero, A; Frassineti, L G; Silvestris, N; Corsi, D; Galli, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 583PThromboembolic risk and survival with Khorana score in resected colorectal cancer patients: Subgroup analysis from the adjuvant TOSCA trial. (23rd October 2018) Authors: Barni, S; Rosati, G; Zagonel, V; Pella, N; Banzi, M; Zampino, M G; Di Bartolomeo, M; Rimassa, L; Marchetti, P; Maiello, E; Artioli, F; Ferrari, D; Labianca, R; Bidoli, P; Zaniboni, A; Sobrero, A; Iaffaioli, V; de Placido, S; Frassineti, L G; Galli, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 96PAXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT) + cetuximab in RAS wild type (WT) patients (pts). (23rd October 2018) Authors: Cardone, C; Blauensteiner, B; Moreno-Viedma, V; Paul, M C; Martini, G; Vitiello, P P; Ciardiello, D; Borrelli, C; Poliero, L; Vitale, P; Zanaletti, N; Famiglietti, V; Rachiglio, A M; Rizzi, D; Maiello, E; Latiano, T P; Normanno, N; Sibilia, M; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LBA-007Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC. (2nd July 2019) Authors: Cremolini, C; Antoniotti, C; Lonardi, S; Rossini, D; Morano, F; Cordio, S; Bergamo, F; Marmorino, F; Maiello, E; Passardi, A; Masi, G; Tamburini, E; Santini, D; Grande, R; Zaniboni, A; Granetto, C; Murgioni, S; Aprile, G; Delliponti, L; Boni, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA20TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts). (23rd October 2018) Authors: Cremolini, C; Antoniotti, C; Lonardi, S; Rossini, D; Pietrantonio, F; Cordio, S S; Murgioni, S; Marmorino, F; Maiello, E; Passardi, A; Masi, G; Tamburini, E; Santini, D; Grande, R; Zaniboni, A; Granetto, C; Loupakis, F; Delliponti, L; Boni, L; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-134Real-world guideline application in the management of pancreatic cancer patients: the Italian GARIBALDI study. (2nd July 2019) Authors: Reni, M; Bergamo, F; Cavanna, L; Spada, M; Ghidini, M; Giommoni, E; Maiello, E; Artioli, F; Cardellino, G; Torri, V; Cinquini, M; Giugliano, V; Pinto, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PD-019Optimizing treatment with anti-epidermal growth factor receptor drugs for patients with metastatic colorectal cancer: novel mechanisms of resistance beyond RAS. (2nd July 2019) Authors: Cardone, C; Blauensteiner, B; Moreno-Viedma, V; Paul, M; Martini, G; Troiani, T; Vitiello, P; Ciardiello, D; Poliero, L; Borrelli, C; Rachiglio, A; Rizzi, D; Maiello, E; Latiano, T; Normanno, N; Sibilia, M; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial. (7th August 2017) Authors: Normanno, N; Esposito Abate, R; Lambiase, M; Forgione, L; Cardone, C; Iannaccone, A; Sacco, A; Rachiglio, A M; Martinelli, E; Rizzi, D; Pisconti, S; Biglietto, M; Bordonaro, R; Troiani, T; Latiano, T P; Giuliani, F; Leo, S; Rinaldi, A; Maiello, E; Ciardiello, F Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗